Adagio Medical Holdings (ADGM) Income from Continuing Operations (2023 - 2026)
Adagio Medical Holdings (ADGM) reported Income from Continuing Operations of 6804000.0 for Q1 2026, up 26.34% on a YoY basis from 5385479.69 in Q1 2025, and down 47.56% sequentially from 4611000.0 in Q4 2025.
Adagio Medical Holdings (ADGM) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Adagio Medical Holdings (ADGM) has 4 years of Income from Continuing Operations data on file, last reported at 6804000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 26.34% year-over-year to 6804000.0; the trailing twelve-month figure through Mar 2026 stood at 28036000.0 (up 50.4% YoY), and the FY2025 full-year result was 62613000.0, up 0.87% from the prior year.
- Income from Continuing Operations slipped to 6804000.0 in Q1 2026, from 4611000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 4611000.0 in Q4 2025 to a low of 32957000.0 in Q2 2024.
- A 4-year average of 10095800.0 and a median of 8037000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Peak annual rise in Income from Continuing Operations reached 83.81% in 2025, while the deepest fall reached 137.15% in 2025.
- Tracing ADGM's Income from Continuing Operations over 4 years: stood at 6837000.0 in 2023, then jumped by 30.39% to 4759000.0 in 2024, then increased by 3.11% to 4611000.0 in 2025, then plunged by 47.56% to 6804000.0 in 2026.
- Business Quant data shows ADGM's Income from Continuing Operations at 6804000.0 in Q1 2026, 4611000.0 in Q4 2025, and 11286000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Adagio Medical Holdings | 21.49 Mn | 21.49 Mn | - | -6.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.80 Mn |
| Dec 31, 2025 | -4.61 Mn |
| Sep 30, 2025 | -11.29 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Mar 31, 2025 | -9.24 Mn |
| Sep 30, 2024 | -4.76 Mn |
| Jun 30, 2024 | -32.96 Mn |
| Mar 31, 2024 | -9.57 Mn |
| Dec 31, 2023 | -6.84 Mn |
| Sep 30, 2023 | -9.56 Mn |